News

Special Sections

Edward Kim | Equities.com |

Merck's blockbuster drug wins another indication in the ongoing cancer battle.


AP News | Equities.com |

Wall Street futures point to gains at open.


Edward Kim | Equities.com |

Multi-year deal with Acerta Pharma, AstraZeneca's hematology research and development arm.


Ivan Martchev | Equities.com |

If there are massive military operations against Iran, the Kurds in Iraq may very well seize the moment and finally get what they have been wanting for decades.


AP News | Equities.com |

Brent crude futures spiked more than $3 per barrel to $71.75 in London before retreating.


IRIS.xyz | Equities.com |

A tit-for-tat retaliation game with Iran may not derail the bullish outlook.


Edward Kim | Equities.com |

The company is pursuing dermatological therapies, with its lead product candidate in Phase 3 clinical trials for plaque psoriasis.


Edward Kim | Equities.com |

BAVENCIO is the first immunotherapy to significantly prolong overall survival in locally advanced or metastatic urothelial carcinoma in the first-line setting in a Phase III trial.


AP News | Equities.com |

Banks and other financial companies led the losses, while energy companies are holding up well.


David Nelson, CFA CMT | Equities.com |

What do the latest events in Iran mean for investors, and should we succumb to our worst fears?



Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum


Trending Articles

  • No items found.